Liposomal Triamcinolone acetonide: Influence of composition in performance and stability;Liposomas de acetónido de triamcinolona: Influencia de la composición en el rendimiento y estabilidad

Ars Pharmaceutica

Volumn 48, Issue 1, 2007, Pages 19-29

  Clares, B ^a   Medina, M M ^a  

^a Facultad de Farmacia   (Spain)

Author keywords

Biophase; Liposomes; Triamcinolone acetonide; Vector

Indexed keywords

CHOLESTEROL; LIPOSOME; TRIAMCINOLONE ACETONIDE;

ARTICLE; CRYOPRESERVATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; LIPOSOMAL DELIVERY; ROOM TEMPERATURE; STORAGE TEMPERATURE;

EID: 34347244224     PISSN: 00042927     EISSN: 00042927     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Puisieux F, Poly PA. Problèmes technologiques posés par l'utilisation des liposomes comme vecteurs de substances médicamenteuses, encapsulation, stérilisation, conservation In "Les liposomes, applications thérapeutiques" Puisieux F. Delattre J. (Eds). Technique &. Documentation, París, 1985.
2. Banciu M, Schiffelers RM, Fens MH, Metselaar JM, Storm G. Anti-angiogenic effects of liposomal pednisolone phosphate on B16 melanoma in mice. J. Control. Release 2006; 113(1):1-8.
3. Jain SK, Jain RK, Chourasia MK, Jain AK, Chalasani KB, Soni V, Jain A. Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS Pharm. Sci. Tech 2005; 06(01): E35-E41.
4. Laginha K, Mumbengegwi D. Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity. Biochim Biophys Acta 2005; 1711: 25-32.
5. Maierhofer G. Introducción a una Nueva Tecnología y Descripción de Técnicas Preparativas. Farm. Clín. 1988; 5: 658-680.
6. Díez O. Aplicación de nuevos sistemas de liberación prolongada en cosmética. NCP 2004; 276: 5-22.
7. Couvreur P, Kante B, Lenaerts V, Guiot P, Roland M. Tissue distribution of 3H-actinomicin D adsorbed on Polybutilcianoacrylate Nanoparticles. Int. J. Pharm. 1980; 7: 45-53.
8. Zhang C, Tang N, Liu X, Liang W, Xu W, Torchilin VP. siRNA-Containing liposomes modified with polyarginine silence the targeted gene. J. Control. Release 2006; 112(2): 229-239.
9. Chiu SJ, Liu S, Perrotti D, Marcucci G, Lee RJ. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferring receptor-targeted liposomes. J. Control. Release 2006; 112(2): 199-207.
10. Chou HH, Wang KL, Chen CA, Wei LH, Hsieh CY, Yang YC, Twu NF, Chang TC, Yen MS. Pegylated liposomal doxorubicin (Lipo-Dox)) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-cerm follow-up. Gynecol Oncology 2006; 101(3):423-428.
11. Frenkel V, Etherington A, Greene M, Quijano J, Xie J, Hunter F, Dromi S, Li KC. Delivey of liposomal doxorubicin (doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. Acad. Radiology 2006; 13(4): 469-79.
12. Cagnoni J. Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. J. Antimicrobial Chemotherapy 2002; 49: 81-86
13. Schiffelers R, Storm G, Bakker-Woudenberg I. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J. Antimicrobial Chemotherapy 2001; 48: 333-344.
14. Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J. Pharm. Pharmaceut. Sci. 2004; 7: 252-259.
15. Elzainy AW, Gu X, Simons FE, Simons KJ. Cetirizine from topical phosphatidylcholine-hydrogenated liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model. AAPS J. 2004; 6 (3): article 18.
16. Cevc G, Blume G, Schatzlein A. Transfersomers mediated. Transepidermal delivery improves the regio-specificity and biological-activity of corticosteroids in-vivo. J. Control. Release 1997; 45: 211-226.
17. Mezei M, Gulasekharam V. Liposomes, a Selective Drug Delivery Sistem for the Topical Route of Administration. I, Lotion Dosage form. Life Sci. 1980; 26: 1473-1477.
18. Bangham AD, Hill MW, Miller NGA. Preparation and use of liposomes as models of biological membranes In "Methods in membrane biology", publié par Korn E.D. Plenum Press, New York 1974; 1: 1-68.
19. Puisieux F. Les liposomes: classification et obtention. Labo. Pharma. Probl. Tech. 1978; 281: 899-904.
20. 6: elaboración y caracterización. XXIX Congreso de A.E.F.H.. tomo I. Alicante 1984; 383-391, 399-408.
21. Hunt CA, Tsang S. Tocopherol retards autoxidation and prolongs the shelf life of liposomes. Int. J. Pharm. 1981; 8: 101-110.
22. Vasson MP, Colombat A, Madelmont JC, Moreau MF, Godeneche D, Delattre J. Etude comparative de l'encapsulation dans les liposomes de nitroso-ureas. Premier Congrès Européen de Biopharmacie et Pharmacocinetique. Vol. I. Clermont-Ferrand 1981; 381.
23. Duforc J. Phyco-chimie des Phospholipides In "Les liposomes, applications thérapeutiques", Puisieux F. et Delattre J. (Eds), Technique & Documentation, París 1985; 1-10.
24. Guzmán M. "Los liposomas, vehículos de medicamentos cardiotónicos. Tesis Doctoral Facultad de Farmacia de Alcalá de Henares 1995.
25. Joshi MR, Misra A. Liposomal budesonide for dry powder inhaler: preparation an stabilization. Pharm. Sci. Tech. 2001; 2(4).
26. Virtanen JA, Ruonala M, Vauhkonen M, Somerharju P. Lateral organization of liquid-crystalline colesterol-dimyristoylphosphatidylcholine bilayers. Evidence for domains with hexagonal and centered rectangular cholesterol superlattices. Biochemistry 1995; 34: 11568-11581.
27. Mc Mullen JN, Newton DW, Becker CH. Pectin-gelatin complex cohacervates part 2. Effect of microemcapsulates sulfamerazine on size, morphology, recovery and straction of water dispersible microglobules. J. Pharm. Sci.1984; 73: 1799-1803.